Kuros Biosciences AG (LON:0RHR)

Kuros Biosciences AG Statistics

Total Valuation

LON:0RHR has a market cap or net worth of GBP 1.02 billion. The enterprise value is 1.01 billion.

Market Cap	1.02B
Enterprise Value	1.01B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	38.37M
Shares Outstanding	n/a
Shares Change (YoY)	+3.76%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	26.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.32
PB Ratio	19.70
P/TBV Ratio	47.59
P/FCF Ratio	566.03
P/OCF Ratio	368.64
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-265.83
EV / Sales	14.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	557.66

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.03.

Current Ratio	2.14
Quick Ratio	1.63
Debt / Equity	0.03
Debt / EBITDA	0.66
Debt / FCF	0.88
Interest Coverage	0.72

Financial Efficiency

Return on equity (ROE) is -6.44% and return on invested capital (ROIC) is 0.11%.

Return on Equity (ROE)	-6.44%
Return on Assets (ROA)	0.09%
Return on Invested Capital (ROIC)	0.11%
Return on Capital Employed (ROCE)	0.17%
Revenue Per Employee	545,897
Profits Per Employee	-30,996
Employee Count	122
Asset Turnover	0.97
Inventory Turnover	1.18

Taxes

In the past 12 months, LON:0RHR has paid 326,144 in taxes.

Income Tax	326,144
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +126.67% in the last 52 weeks. The beta is 0.92, so LON:0RHR's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	+126.67%
50-Day Moving Average	26.08
200-Day Moving Average	23.02
Relative Strength Index (RSI)	56.19
Average Volume (20 Days)	7,785

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RHR had revenue of GBP 66.60 million and -3.78 million in losses. Loss per share was -0.10.

Revenue	66.60M
Gross Profit	59.18M
Operating Income	94,317
Pretax Income	-2.95M
Net Income	-3.78M
EBITDA	1.81M
EBIT	94,317
Loss Per Share	-0.10

Balance Sheet

The company has 15.88 million in cash and 1.58 million in debt, giving a net cash position of 14.30 million.

Cash & Cash Equivalents	15.88M
Total Debt	1.58M
Net Cash	14.30M
Net Cash Per Share	n/a
Equity (Book Value)	51.78M
Book Value Per Share	1.37
Working Capital	21.03M

Cash Flow

In the last 12 months, operating cash flow was 2.77 million and capital expenditures -965,209, giving a free cash flow of 1.80 million.

Operating Cash Flow	2.77M
Capital Expenditures	-965,209
Free Cash Flow	1.80M
FCF Per Share	n/a

Margins

Gross margin is 88.85%, with operating and profit margins of 0.14% and -5.68%.

Gross Margin	88.85%
Operating Margin	0.14%
Pretax Margin	-4.43%
Profit Margin	-5.68%
EBITDA Margin	2.72%
EBIT Margin	0.14%
FCF Margin	2.71%

Dividends & Yields

LON:0RHR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.76%
Shareholder Yield	n/a
Earnings Yield	-0.37%
FCF Yield	0.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RHR has an Altman Z-Score of 11.67 and a Piotroski F-Score of 5.

Altman Z-Score	11.67
Piotroski F-Score	5